Source 1review2015Thyroid
Toolkit/serum thyroglobulin surveillance
serum thyroglobulin surveillance
Also known as: serum thyroglobulin
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin
Usefulness & Problems
Why this is useful
Serum thyroglobulin is used for surveillance of recurrent disease in long-term differentiated thyroid cancer management. The abstract presents it together with imaging rather than as a solitary follow-up tool.; long-term surveillance for recurrent differentiated thyroid cancer
Source:
Serum thyroglobulin is used for surveillance of recurrent disease in long-term differentiated thyroid cancer management. The abstract presents it together with imaging rather than as a solitary follow-up tool.
Source:
long-term surveillance for recurrent differentiated thyroid cancer
Problem solved
It helps monitor patients for recurrence after initial thyroid cancer management.; supports monitoring for recurrent disease
Source:
It helps monitor patients for recurrence after initial thyroid cancer management.
Source:
supports monitoring for recurrent disease
Problem links
supports monitoring for recurrent disease
LiteratureIt helps monitor patients for recurrence after initial thyroid cancer management.
Source:
It helps monitor patients for recurrence after initial thyroid cancer management.
Published Workflows
Objective: Guide evidence-based diagnosis and management of adult thyroid nodules and differentiated thyroid cancer across initial evaluation, treatment selection, and long-term follow-up.
Why it works: The abstract describes a staged management logic in which initial evaluation informs biopsy decisions, biopsy interpretation and molecular markers refine diagnosis, and later surveillance uses imaging and serum thyroglobulin to monitor recurrent disease.
ultrasound-based biopsy triagebiopsy result interpretationmolecular-marker-informed evaluationimaging and serum thyroglobulin surveillanceelectronic database searchingcitation review and selectioncritical appraisalevidence grading
Stages
- 1.Initial evaluation of thyroid nodules(functional_characterization)
The abstract identifies initial evaluation as the first recommendation area for thyroid nodules.
Selection: Initial clinical evaluation before biopsy decisions
- 2.Clinical and ultrasound criteria for fine-needle aspiration biopsy(decision_gate)
This stage narrows which nodules undergo biopsy.
Selection: Clinical and ultrasound criteria determine whether FNA biopsy is indicated
- 3.Interpretation of fine-needle aspiration biopsy results(secondary_characterization)
Biopsy interpretation is explicitly named as a recommendation area after FNA decision-making.
Selection: Biopsy results are interpreted to inform management
- 4.Use of molecular markers(secondary_characterization)
The abstract lists molecular markers after FNA result interpretation, implying an adjunctive refinement stage.
Selection: Molecular-marker information is incorporated into thyroid nodule management
- 5.Staging and risk assessment for thyroid cancer(functional_characterization)
The abstract explicitly includes staging and risk assessment in initial thyroid cancer management.
Selection: Risk assessment informs initial thyroid cancer management
- 6.Initial thyroid cancer management(confirmatory_validation)
The abstract groups these interventions as initial management recommendations.
Selection: Management options include surgery, radioiodine remnant ablation and therapy, and levothyroxine-based thyrotropin suppression therapy
- 7.Long-term surveillance for recurrent disease(confirmatory_validation)
The abstract explicitly identifies surveillance for recurrent disease as part of long-term management.
Selection: Surveillance uses imaging and serum thyroglobulin
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The abstract supports use in a surveillance setting and indicates that imaging is a companion modality in the same follow-up framework.; used in long-term follow-up; paired with imaging for surveillance
The abstract does not state that serum thyroglobulin alone is sufficient for all recurrence detection or management decisions.; the abstract does not provide surveillance thresholds, timing, or comparative performance
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The guideline covers initial thyroid cancer management topics including screening, staging and risk assessment, surgical management, radioiodine remnant ablation and therapy, and levothyroxine-based thyrotropin suppression therapy.
The guideline covers long-term differentiated thyroid cancer management including surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, recurrent and metastatic disease management, and consideration of clinical trials and targeted therapy.
Approval Evidence
1 source1 linked approval claimfirst-pass slug serum-thyroglobulin-surveillance
Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin
Source:
review scope summarysupports
The guideline covers long-term differentiated thyroid cancer management including surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, recurrent and metastatic disease management, and consideration of clinical trials and targeted therapy.
Source:
Comparisons
Source-stated alternatives
The abstract names imaging as the adjacent surveillance approach used alongside serum thyroglobulin.
Source:
The abstract names imaging as the adjacent surveillance approach used alongside serum thyroglobulin.
Source-backed strengths
explicitly named as part of long-term surveillance
Source:
explicitly named as part of long-term surveillance
Compared with imaging
The abstract names imaging as the adjacent surveillance approach used alongside serum thyroglobulin.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly named as part of long-term surveillance.
Relative tradeoffs: the abstract does not provide surveillance thresholds, timing, or comparative performance.
Source:
The abstract names imaging as the adjacent surveillance approach used alongside serum thyroglobulin.
Compared with imaging surveillance
The abstract names imaging as the adjacent surveillance approach used alongside serum thyroglobulin.
Shared frame: source-stated alternative in extracted literature
Strengths here: explicitly named as part of long-term surveillance.
Relative tradeoffs: the abstract does not provide surveillance thresholds, timing, or comparative performance.
Source:
The abstract names imaging as the adjacent surveillance approach used alongside serum thyroglobulin.
Ranked Citations
- 1.